Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19521 

year, plans for the coming year, a budget 

request for the next grant year, with 

complete justification, and appropriate 

signatures, and be submitted using Form 

OPHS–1. A Financial Status Report 

(FSR) SF–269 is due 90 days after the 

close of each 12-month budget period. A 

copy of the form will be sent with the 

Notice of Grant Award. 

VII. Agency Contact(s) 

For Application Kits, submission of 

applications, and information on budget 

and business aspects of the application, 

please contact: WilDon Solutions, Office 

of Grants Management Operations 

Center, 1515 Wilson Boulevard, Third 

Floor Suite 310, Arlington, VA 22209 at 

1–888–203–6161, e-mail 

OPHSgrantinfo@teamwildon.com, or fax 

703–351–1138. Also contact Wildon 

Solutions with questions regarding 

programmatic information and/or 

requests for technical assistance in the 

preparation of the grant application. 

VIII. Other Information 

Not applicable. 

Dated: April 13, 2007. 

Wanda K. Jones, 

Deputy Assistant Secretary for Health 

(Women’s Health), Office of Public Health 

and Science. 

[FR Doc. E7–7371 Filed 4–17–07; 8:45 am] 

BILLING CODE 4150–33–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood Safety and Availability 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services is hereby giving notice that the 

Advisory Committee on Blood Safety 

and Availability (ACBSA) will hold a 

meeting. The meeting will be open to 

the public on both Thursday, May 10 

and Friday, May 11, 2007. 

DATES: The meeting will take place 

Thursday, May 10, 2007 and Friday, 

May 11, 2007 from 9 a.m. to 5 p.m. 

ADDRESSES: Georgetown University 

Conference Center, 3800 Reservoir 

Road, NW., Washington, DC 20057. 

FOR FURTHER INFORMATION CONTACT: Jerry 

A. Holmberg, PhD, Executive Secretary, 

Advisory Committee on Blood Safety 

and Availability, Office of Public Health 

and Science, Department of Health and 

Human Services, 1101 Wootton 

Parkway, Room 250, Rockville, MD 

20852, (240) 453–8803, FAX (240) 453–

8456, e-mail ACBSA@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

ACBSA will receive updates on 

previous recommendations to include 

variant Creutzfeldt Jacob Disease (vCJD), 

Chagas, Transfusion Related Acute Lung 

Injury (TRALI) and West Nile Virus. 

Since the last meeting, the 

Committee’s Charter was modified and 

approved by Secretary Leavitt in 

October 2006 to include broad public 

health, ethical and legal issues related to 

transfusion and transplantation safety. 

In order to understand these areas of 

commonality, the main topic of this 

meeting will center on presentations 

and discussion of common concerns in 

transfusion and transplantation safety. 

The new charter permits the 

expansion of the Committee ex-officio 

members to include agencies other than 

those currently having a permanent exofficio seat. Representation from the 

Division of Organ Transplantation 

within the Health Resources and 

Services Administration (HRSA) and the 

Office of Cellular, Tissue, and Gene 

Therapy within the Food and Drug 

Administration (FDA) will be added as 

Committee ex-officio members. 

Public comment will be solicited on 

Thursday, May 10, at noon and Friday, 

May 11, before noon. Comments will be 

limited to five minutes per speaker. 

Anyone planning to comment is 

encouraged to contact the Executive 

Secretary at his/her earliest 

convenience. Those who wish to have 

printed material distributed to Advisory 

Committee members should submit 

thirty (30) copies to the Executive 

Secretary prior to close of business May 

7, 2007. Likewise, those who wish to 

utilize electronic data projection to the 

Committee must submit their materials 

to the Executive Secretary prior to close 

of business May 7, 2007. 

Dated: April 13, 2007. 

Jerry A. Holmberg, 

Executive Secretary, Advisory Committee on 

Blood Safety and Availability. 

[FR Doc. E7–7340 Filed 4–17–07; 8:45 am] 

BILLING CODE 4150–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Adopting and 

Demonstrating the Adaptation of 

Prevention Techniques for Persons at 

Highest Risk of Acquiring or 

Transmitting Human 

Immunodeficiency Virus (ADAPT2), 

Funding Opportunity Announcement 

(FOA) Number PS07–004 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the 

aforementioned Special Emphasis 

Panel. 

Time and Date: 

8:30 a.m.–9 a.m., May 18, 2007 

(Open). 

9 a.m.–4 p.m., May 18, 2007 

(Closed). 

Place: Sheraton Midtown Atlanta 

Hotel at Colony Square, 188 14th Street, 

Atlanta, GA 30361. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c)(4) 

and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92–

463. 

Matters to be Discussed: The meeting 

will include the review, discussion, and 

evaluation of a research application in 

response to FOA PS07–004, ‘‘Adopting 

and Demonstrating the Adaptation of 

Prevention Techniques for Persons at 

Highest Risk of Acquiring or 

Transmitting Human Immunodeficiency 

Virus (ADAPT2).’’

Contact Person For More Information: 

J. Felix Rogers, M.P.H., PhD, Scientific 

Review Administrator, Extramural 

Research Program Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE., MS E05, Atlanta, GA 

30333, telephone 404.639.6101. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 


pwalker on PROD1PC71 with NOTICES
19522 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 

Dated: April 10, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7331 Filed 4–13–07; 10:39 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel ‘‘Health Promotion 

and Disease Prevention Research 

Centers: Special Interest Project 

Competitive Supplements (Panel 7),’’

Request for Application Number (RFA) 

DP07–002 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the 

aforementioned Special Emphasis 

Panel. 

Time and Date: 12 p.m.–4 p.m., June 5, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of research grant applications 

received in response to RFA DP07–002, 

‘‘Health Promotion and Disease Prevention 

Research Centers: Special Interest Project 

Competitive Supplements (Panel 7).’’

Contact Person for More Information: 

Sheree Marshall Williams, PhD, M.Sc., 

Scientific Review Administrator, Centers for 

Disease Control and Prevention, 1600 Clifton 

Road, NE., MS D72, Atlanta, GA 30333, 

telephone 404.639.4896. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: April 10, 2007. 

Elaine L. Baker 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7332 Filed 4–17–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group 

(NCIPC/IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meetings of the 

aforementioned committee: 

Times and Dates: 

2 p.m.–5 p.m., May 14, 2007 (Closed). 

2 p.m.–5 p.m., May 15, 2007 (Closed). 

2 p.m.–5 p.m., May 16, 2007 (Closed). 

2 p.m.–5 p.m., May 17, 2007 (Closed). 

2 p.m.–5 p.m., May 18, 2007 (Closed). 

Place: The conference calls will 

originate at the Centers for Disease 

Control and Prevention, Vanderbilt 

Building, Koger Center, Atlanta, 

Georgia. 

Times and Dates: 

9 a.m.–10 a.m., May 21, 2007 (Open). 

10 a.m.–5 p.m., May 21, 2007 

(Closed). 

9 a.m.–3 p.m., May 22, 2007 (Closed). 

3 p.m.–5 p.m., May 22, 2007 (Open). 

5 p.m.–7 p.m., May 22, 2007 (Closed). 

9 a.m.–5:30 p.m., May 23, 2007 

(Closed). 

9 a.m.–5 p.m., May 24, 2007 (Closed). 

Place: Sheraton Midtown Atlanta 

Hotel Colony Square, Atlanta, Georgia. 

Status: Portions of the meetings will 

be closed to the public in accordance 

with provisions set forth in Section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Section 10(d) 

of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services, and the Director, CDC, 

concerning the scientific and technical 

merit of grant and cooperative 

agreement applications received from 

academic institutions and other public 

and private profit and nonprofit 

organizations, including State and local 

government agencies, to conduct 

specific injury research that focuses on 

prevention and control. 

Matters to be Discussed: The meeting 

will include the review, discussion, and 

evaluation of individual research grant 

and cooperative agreement applications 

submitted in response to two Fiscal 

Year 2007 Requests for Applications 

related to the following individual 

research announcements: 07002, Family 

and Dyadic Focused Interventions to 

Prevent Intimate Partner Violence; 

07003, Maximizing Protective Factors 

for Youth Violence; 07004, Abusive 

Head Trauma (AHT) Prevention; 07005, 

Understanding Bullying and Sexual 

Violence Perpetration and Factors 

Associated with Both Outcomes; 07006, 

Grants for Traumatic Injury 

Biomechanics Research; 07007, 

Dissemination Research on Fall 

Prevention: ‘‘Stepping On’’ in a U.S. 

Community Setting; and 07008, The 

Impact of Traumatic Brain Injury 

Among Incarcerated Persons. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Jane Suen, PhD, NCIPC/IRG, CDC, 4770 

Buford Highway, NE., M/S K02, Atlanta, 

Georgia 30341–3724, telephone 770/ 

488–1240. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: April 10, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7339 Filed 4–17–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1080, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 72 FR 14578, dated 

March 28, 2007) is amended to reflect 

the reorganization of the Coordinating 

Center for Infectious Diseases, Centers 

for Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the mission 

statements for the Coordinating Center 

for Infectious Diseases (CV) and the 

Office of the Director (CVA), and insert 

the following: 


pwalker on PROD1PC71 with NOTICES